Isamu Okamoto

27PUBLICATIONS
109CO-AUTHORS
Haematological tumoursPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|May 18, 2026
Incidence of B cell malignancies in patients with lung cancer receiving PD-1 blockade therapy.

|Jan 20, 2026
Epigenetic Dysregulation of the NKX2-1/SPDEF Axis Drives Persistent Goblet Cell Differentiation and Epithelial Barrier Dysfunction in Chronic Obstructive Pulmonary Disease.

Ayaka Shiota, Keiko Kan-O, Yumiko Ishii

|Sep 01, 2025
Association Between Single Nucleotide Polymorphisms and Disease Susceptibility, Survival, and Acute Exacerbation in Idiopathic Pulmonary Fibrosis.

Kazuya Tsubouchi, Toyoshi Yanagihara, Fumiaki Kiyomi

|Apr 23, 2025
Chest Tube Drainage, Bone Radiotherapy, and Brain Radiotherapy in Advanced Lung Cancer: A Retrospective Analysis of Associated Factors and Survival.

Shoko Sonobe Shimamura, Takehito Shukuya, Kazuhisa Takahashi

|Jan 13, 2025
Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy.

Toshifumi Ninomiya, Naoya Kemmotsu, Fumiaki Mukohara

|Oct 29, 2024
TROPION-Lung07: Phase III study of Dato-DXd + pembrolizumab ± platinum-based chemotherapy as 1L therapy for advanced non-small-cell lung cancer.

Isamu Okamoto, Shoichi Kuyama, Nicolas Girard

Pageof 5

Frequent Collaborators

5 joint publications

Shunichi Sugawara

3 joint publications

Toyoaki Hida

2 joint publications

Hidehito Horinouchi

2 joint publications

Kazuya Tsubouchi